| Literature DB >> 28967068 |
Alexandra C Kölbl1, Kristina Schlenk1, Nils Behrendt1, Ulrich Andergassen1.
Abstract
Human chorionic gonadotropin (hCG) is a peptide hormone which plays an important role during pregnancy. But its impact is not limited to pregnancy; it also influences tumor formation and metastatic outgrowth, especially in endometrial adenocarcinoma and breast cancer. This review summarizes what has been written in the literature about the role of hCG as a tumor marker in these 2 gynecological malignancies and also about the signal transduction pathways in which hCG is involved. HCG can, on the one hand, be a marker for the progression of a malignant disease, and on the other hand, it may be a point for therapeutical intervention, so further research into this molecule would be very much worthwhile.Entities:
Keywords: Breast cancer; Endometrial adenocarcinoma; Therapy; Tumor marker; hCG
Mesh:
Substances:
Year: 2018 PMID: 28967068 DOI: 10.5301/ijbm.5000290
Source DB: PubMed Journal: Int J Biol Markers ISSN: 0393-6155 Impact factor: 2.659